跳至主要内容
临床试验/NCT05650944
NCT05650944已完成不适用

Department of Infectious Disease and Clinical Microbiology

Hisar Intercontinental Hospital1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
125
试验地点
1
主要终点
Hematological parameters in the prognosis of severe Covid-19 patients.

研究概览

简要总结

It is aimed to reveal the treatment and prognostic values by evaluating the differences in hematological parameters and indices, especially in dead Covid-19 cases.

Material Method: It is planned to retrospectively examine the hemogram parameters of 125 male, 44 female and 169 critical Covid-19 patients hospitalized between 01.03.2020 and 31.12.2021. Subjects were divided into 2 groups as deceased (77) and living (92) patients according to demographic data such as age and gender.

Statistical evaluation: All analyzes were SPSS 25.0, Kolmogorov Smirnov test was used to determine distribution, median and interquartile range (Tukey's Hinges Percentile) were used to summarize variables. The differences between the Independent-Samples Mann Whitney U Test and the data of the patient groups and the optimal cut-off values, sensitivity and specificity values will be determined by ROC analysis. It will be considered statistically significant when the p value is below 0.05 (with the two-tailed test)

详细描述

The aim of this study is to examine the effectiveness of routine laboratory complete blood count parameters and rates as diagnostic and prognostic criteria in severe COVID-19.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over the age of 18
  • Critical patients taken to intensive care
  • The length of stay in the ICU is more than 24 hours

排除标准

  • Patients under 18 years of age (2) Patients with hematological malignancies (3) The length of stay in the ICU is less than 24 hours.

结局指标

主要结局

Hematological parameters in the prognosis of severe Covid-19 patients.

时间窗: 2020-2021

Hemogram values of the deceased and surviving patients participating in the study were compared.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ramazan Gozukucuk

Principal Investigator

Hisar Intercontinental Hospital

研究点 (1)

Loading locations...

相似试验

How Important Are Hematological Parameters in the... | 临床试验